Glow Lifetech Corp.

OTC: GLWLF · Healthcare · Biotechnology

Canadian filerHQ Toronto, ONReports USD

#824 of 1,394 Healthcare companies by revenuetop-quartile growth

EA Score

——

FH 61DQ —GM —SS 25

v0.1 · 35/100 weight · pillars only

↑ revenue growth (YoY), balance-sheet leverage · ↓ listing tenure, workforce scale

Methodology →

Revenue TTM

$1.6M

Rev growth YoY (TTM)

+94.4%

Net income (FY)

-$441.6k

Employees

Market cap

$6.4M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$1.5M2.1M CAD2025

Net income-$441.6k-617.4k CAD2025

Operating income-$520.2k-727.2k CAD2025

Total assets$2.9M3.9M CAD2025

Liabilities$879.8k1.2M CAD2025

Equity$2.0M2.7M CAD2025

Revenue trend

FY2019 – FY2025 · USD

FY19

FY20

FY21

FY22

$32.5k

FY23

$610.5k

FY24

$1.5M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Glow Lifetech Corp. booked $1.5M in FY2025 revenue, growing 140% year over year — faster than most Healthcare companies we track, at a -30.1% net margin.

Peers · Healthcare

Citius Pharmaceuticals, Inc.43D AI Maverick Intel, Inc.——Sweet Earth Holdings Corporation22D AI/ML Innovations Inc.30D

Key facts

CEORoberto Paolo Carducci

SectorHealthcare

IndustryBiotechnology

HeadquartersToronto, ON

ExchangeOTC: GLWLF

Employees5

IPO date2021-10-28

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.